Hologic said Wednesday that Kevin Thornal, group president of its Global Diagnostics Solutions business, has tendered his resignation effective Friday this week.
Thornal is leaving Hologic to assume the role of CEO at a publicly traded company, the firm said in a document filed with the U.S. Securities and Exchange Commission.
Jennifer Schneiders, PhD, currently vice president of US sales and commercial excellence for the Diagnostics Solutions Division, will on Friday assume the role of president, Diagnostics Solutions.
Redwood City, CA-based Nevro, a medical device company, announced Wednesday that it has appointed Thornal as its CEO.